Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XBI vs. BBC: which is better?

Bottom line

XBI vs BBC: the short answer

XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and BBC (Virtus Biotech Clinical Trials ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.

XBI is cheaper at 0.35% vs 0.65% — a difference of $30 a year per $10,000 invested.

Over five years, XBI returned −2.7% a year vs −4.3% for BBC.

Updated Nov 19, 2026

XBI vs BBC side by side

XBIBBC
TypeETFETF
Fund familySPDR (State Street)Virtus
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.65%
Annual cost per $10k$35$65
10-yr cost on $10k (prospectus)$443$810
Max front loadNoneNone
12b-1 fee0%—
1-yr return+35.8%+63.8%
5-yr return (annualized)−2.7%−4.3%
10-yr return (annualized)+5.8%+3.3%
Best quarter+44.4%+59.4%
Worst quarter−26.2%−34.5%
Net assets (fund)$10.7B$46.4M
Number of holdings161132
Portfolio turnover71%53%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXBIBBCDifference
2025+35.8%+63.8%−28.0%
2024+1.1%−0.9%+2.0%
2023+7.5%−1.6%+9.1%
2022−25.8%−35.4%+9.6%
2021−20.5%−22.4%+1.8%
2020+48.2%+30.8%+17.4%
2019+32.2%+62.6%−30.4%
2018−14.9%−17.5%+2.6%
2017+43.7%+55.6%−11.9%
2016−15.4%−36.5%+21.1%

Source: Fund prospectus bar charts

Holdings overlap

5 of XBI's top 25 holdings also appear in BBC's top 25.

Shared top holdings
HoldingXBIBBC
Apogee Therapeutics Inc1.49%1.02%
Oruka Therapeutics Inc1.38%0.93%
Erasca Inc1.27%0.87%
SELLAS Life Sciences Group Inc1.19%0.86%
Dianthus Therapeutics Inc1.18%0.87%

Source: SEC Form N-PORT

XBI top 10

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Oruka Therapeutics Inc — 1.38%
  6. Kymera Therapeutics Inc — 1.36%
  7. Viking Therapeutics Inc — 1.30%
  8. Praxis Precision Medicines Inc — 1.29%
  9. Erasca Inc — 1.27%
  10. Revolution Medicines Inc — 1.20%

BBC top 10

  1. Dreyfus Government Cash Manage — 3.48%
  2. First Tracks Biotherapeutics Inc — 1.67%
  3. Mbx Biosciences Inc — 1.24%
  4. Ataibeckley Inc — 1.23%
  5. Monopar Therapeutics Inc — 1.21%
  6. Definium Therapeutics Inc — 1.18%
  7. Xencor Inc — 1.10%
  8. Zenas Biopharma Inc — 1.06%
  9. Uniqure Nv — 1.06%
  10. Apogee Therapeutics Inc — 1.02%

FAQ

What is the difference between XBI and BBC?
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and BBC (Virtus Biotech Clinical Trials ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared. XBI is cheaper at 0.35% vs 0.65% — a difference of $30 a year per $10,000 invested.
Which is cheaper, XBI or BBC?
XBI has the lower expense ratio (0.35%).
Should I own both XBI and BBC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.